Literature DB >> 26538723

Violaceous Maculopapular Rash in a Newborn: Congenital Rubella Syndrome.

Nikita Gandhi1, Vibhu Mendiratta1, Shailja Shukla2, Ritu Rawat1, Shiwangi Rana1, Ram Chander1.   

Abstract

Congenital rubella syndrome involves a configuration of systemic and cutaneous manifestations in a neonate due to in utero infection caused by the rubella virus. The case of a preterm neonate with blueberry muffin lesions and classical as well as rare systemic features of congenital rubella syndrome is reported.

Entities:  

Keywords:  Blueberry muffin; congenital rubella syndrome; violaceous rash

Year:  2015        PMID： 26538723      PMCID： PMC4601444          DOI： 10.4103/0019-5154.164429

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN： 0019-5154            Impact factor:   1.494


  6 in total

1.  Dermal erythropoiesis in congenital rubella. Description of an infected newborn who had purpura associated with marked extramedullary erythropoiesis in the skin and elsewhere.

Authors:  H Z Klein; M Markarian
Journal:  Clin Pediatr (Phila)       Date:  1969-10       Impact factor: 1.168

Review 2.  Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review.

Authors:  Pooja Dewan; Piyush Gupta
Journal:  Indian Pediatr       Date:  2012-05       Impact factor: 1.411

3.  Dermal erythropoiesis in a neonate.

Authors:  J C Argyle; J J Zone
Journal:  Arch Dermatol       Date:  1981-08

4.  Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A.

Authors:  J M Lindquist; S A Plotkin; L Shaw; R V Gilden; M L Williams
Journal:  Br Med J       Date:  1965-12-11

5.  Late onset Blueberry Muffin Syndrome following congenital rubella.

Authors:  A Vozza; C Tolone; E M Carrano; F Di Girolamo; R Santinelli; P A Ascierto; R Toraldo; L Nacca; G Vozza
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-03       Impact factor: 6.166

6.  Cardiovascular defects and the rubella syndrome.

Authors:  R C Way
Journal:  Can Med Assoc J       Date:  1967-11-25       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.